LONDON, Feb 20 (Reuters) - U.S. bankers hungry for opportunities to lend to America's top companies are welcoming a $7 billion financing package backing generic drugmaker Actavis Plc's acquisition of Forest Laboratories.



Read more here >> Reuters | Quail eggs
Read more here >> Reuters | Quail eggs